Form 4: Prothena Corp Public LTD CO: CEO Gene G. Kinney Acquires 375,000 Stock Options
SEC Form 4 Filing
Gene G. Kinney, President and CEO of Prothena Corp Public LTD CO, acquired 375,000 stock options on March 5, 2025, according to a Form 4 filing with the SEC.
Summary
- On March 5, 2025, Gene G. Kinney, the President and CEO of Prothena Corp Public LTD CO, acquired 375,000 stock options.
- The options have an exercise price of $14.95.
- The options vest over a four-year period, starting with 25% vesting on March 5, 2026, and the remainder vesting monthly thereafter, contingent upon continued employment.
- The options expire on March 5, 2035.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports the acquisition of stock options by the CEO.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the compensation structure and equity ownership of key executives.
Stakeholder Impact
- The acquisition of stock options by the CEO could potentially align his interests with those of the shareholders, as his compensation is tied to the company's stock performance.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of transaction: CEO acquired 375,000 stock options. |
| 03/05/2026 | First vesting date: 25% of the options become exercisable. |
| 03/05/2035 | Expiration date of the stock options. |
| 03/07/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.